Sustainability has been an integral part of Janssen's strategic agenda for many years. We want to share our strategy, performance and improvement points with you and offer you the opportunity to thoroughly assess our efforts in relation to sustainability with this second Report to the Community. We believe that effective, transparent reporting and an honest, open dialog about this are important. We want to continue working on sustainable health with you and test and adjust our policy accordingly. 

Inspired by Our Credo, the corporate code that celebrated its 70th birthday in 2013, the Healthcare Model for the Future puts patients first. The changing methods of recognizing, preventing and treating diseases, diagnosing and administering medication give us new and more sustainable options to deal with the huge challenges we are facing.

In 2013, Janssen continued its efforts in the fields of neuroscience, oncology, infectious diseases, immunology and cardiovascular and metabolic diseases. We focus on the discovery and development of a new generation of molecules in the domains of schizophrenia, depression, pain management, Alzheimer's disease, hepatitis C, HIV and different types of cancers. Our search for innovative solutions for some of the most fundamental diseases for which there is, as yet, no satisfactory treatment continues without interruption. 

 

We view continuous innovation and partnerships as the only sustainable path for progress. 

Together with our stakeholders, we are working on worldwide accessibility to qualitative and affordable healthcare. People have little access to high-quality healthcare in quite some regions of the world because of financial, logistical or organizational reasons. This is why Janssen set up Janssen Global Public Health in 2013. This group combines the best of our innovative access models with our mission to improve health in a sustainable manner. We are taking new and daring paths in our aim to make sure that everybody is healthier.

J&J-Sonja-Willems-22082012-3B.jpg

Sonja Willems,
Managing Director Janssen-Cilag Benelux

Heyman_Tom_9185_H.jpg

Tom Heyman,
CEO Janssen Pharmaceutica

Janssen is committed to the wellbeing of the community and its employees. In a world where guaranteed job security is being eroded, we continue to invest in the talent available and the potential capabilities of everyone at our company. Our employees like to work for our company because they have feasible jobs and a good work ability. 

We are also aware of our impact on the environment. We are, therefore, continuing to aim to reduce our water consumption, waste production and emissions and we want more biodiversity. Limiting our energy consumption and the production of green energy are also essential. We are, therefore, starting a feasibility study into a system that uses geothermal energy in 2013. 

We view continuous innovation and partnerships as the only sustainable path for progress. In 2013, we are on our way to an even more intensive partnership between knowledge institutions, companies and the government with our open innovation model to make sure we can expand our knowledge while including all sectors. 

Our focus on sustainable development connects economic growth to social progress and ecological balance. We want to assume our responsibility for the effect thereof on a social, ecological and economic area for the full value chain of our activities. Janssen invests in care innovation and sustainability. This is the path toward the future that serves patients, the community and our employees.

About this
Report

Welcome to this site reporting on the sustainability initiatives of the Janssen Campus in 2013.